What Is Dexcom Clarity? A Diabetes Management App

Dexcom Clarity is a free companion software platform that pulls glucose data from Dexcom continuous glucose monitors (CGMs) and transforms the raw readings into charts, statistics, and trend reports designed to help people with diabetes and their healthcare providers make better treatment decisions. Rather than just displaying a single blood sugar number, Clarity aggregates days or weeks of glucose data into standardized visual reports that highlight patterns you might never catch on your own. The platform is available as a mobile app and a web-based dashboard, and it has become a central tool in how many CGM users review and act on their data between clinic visits.

How Clarity Turns Raw Glucose Data Into Something Useful

A Dexcom CGM sensor reads your interstitial glucose roughly every five minutes, producing hundreds of data points a day and thousands over a two-week wear cycle. That volume of information is essentially unreadable as a list of numbers. Clarity’s primary job is to compress all of that into a format a human can actually interpret. The software automatically collects entries from Dexcom sensors and displays them in its data visualization report tool, which has been used in both clinical care and research settings for years.¹

The centerpiece of what Clarity generates is the Ambulatory Glucose Profile, or AGP. This is a standardized one-page report that has become the agreed-upon way to present CGM data across the diabetes community. The AGP compresses two weeks of glucose readings into a single 24-hour graph, layering each day’s readings on top of one another so that patterns emerge. If your glucose tends to spike every morning at 6 a.m. or drop every afternoon after lunch, the AGP makes those trends immediately visible as shaded bands rather than leaving you to scroll through day after day of individual traces.²

The format was developed specifically because clinicians and researchers recognized that glucose data was being dramatically underutilized. People were generating enormous amounts of information from their monitors but lacked a standard way to view it, which contributed to poor glycemic control.³ The AGP solved that by giving everyone, from endocrinologists to primary care doctors to patients at home, the same visual language. When you open Clarity, you are looking at the same report format your doctor would review during your next appointment.

The Key Numbers Clarity Reports

Beyond the visual graph, Clarity calculates and displays several specific metrics that diabetes specialists now consider essential to understanding glucose control. These go well beyond what a traditional fingerstick blood sugar or even an HbA1c lab test can tell you.

Time in Range (TIR): The percentage of the day your glucose stays within a target window, typically 70–180 mg/dL. International consensus guidelines established TIR as a core metric for everyone using CGM. The general target for most adults with diabetes is at least 70% of the day spent in range, though targets vary for pregnancy, older adults, and children.
Time Below Range (TBR): The percentage of time spent below 70 mg/dL (low) or below 54 mg/dL (very low). Minimizing time below range is critical because hypoglycemia can be immediately dangerous.
Time Above Range (TAR): The percentage of time spent above 180 mg/dL or above 250 mg/dL, reflecting periods of hyperglycemia that, over months and years, contribute to complications.
Glucose Management Indicator (GMI): An estimate of what your HbA1c might be based on your average sensor glucose. This lets you track changes in real time rather than waiting three months for a lab draw.
Glucose variability: Measured as the coefficient of variation (CV), this captures how much your glucose swings up and down. A CV below about 36% is generally the target. Two people can have the same average glucose but very different variability, and the person with wilder swings faces a different set of risks.

Time in Range has gained particular attention because research has linked it to long-term diabetes complications. A systematic review examining TIR and microvascular complications in type 2 diabetes found that each 10% increase in TIR was associated with reductions in albuminuria, severity of diabetic retinopathy, and prevalence of diabetic peripheral neuropathy.⁴ That finding is what makes the TIR number in Clarity more than just a score to chase. It connects daily glucose management directly to the complications people with diabetes worry about most.

Where GMI and Lab HbA1c Disagree

One of the most confusing things Clarity users encounter is when the Glucose Management Indicator doesn’t match their lab-drawn HbA1c. You might see a GMI of 7.2% in Clarity but then get a lab result of 6.5% or 8.0%, and naturally wonder which number to trust. This discordance is more common than most people realize. A real-world analysis found that only about 11% of patients had a difference of less than 0.1% between their HbA1c and GMI, while half had a gap of 0.5% or more, and roughly a fifth had a gap of 1% or larger.⁵

The mismatch happens because HbA1c reflects the lifespan and glycation rate of your red blood cells, which varies from person to person based on genetics, anemia, kidney function, and other biological factors. GMI is a straight mathematical calculation from your average sensor glucose. Neither number is “wrong,” but they measure slightly different things. The discordance is even more pronounced in people with chronic kidney disease, where about two-thirds showed a gap of more than 0.5% compared to roughly 42% of people without kidney disease.⁶ If you have kidney issues or conditions that affect red blood cell turnover, the GMI in Clarity may actually give you a more accurate picture of your day-to-day glucose control than the lab test.

The practical takeaway is that GMI and HbA1c are complementary. When they agree, you have high confidence. When they disagree, it is worth talking with your provider about which one better reflects your situation, rather than assuming one is simply incorrect.

Pattern Detection and Algorithmic Insights

Clarity doesn’t just show you what happened. It tries to highlight why it happened by identifying recurring glucose patterns. The software flags events like consistent post-meal spikes, overnight lows, or afternoon highs that repeat across multiple days. A study examining algorithmic pattern recognition in CGM data identified 29 predefined glucose patterns that could be checked on a weekly basis, and analyzed how persistent those patterns were, which demographic factors influenced them, and how much resolving a given pattern might improve Time in Range.⁷

The idea is to move from “your average glucose was X” to “here is a specific, repeating problem you can act on.” A pattern like “glucose rises above 250 mg/dL between 7 and 9 a.m. on most days” is far more actionable than a summary statistic. It points toward a specific cause, whether that’s a dawn phenomenon, an insulin timing issue, or a breakfast that isn’t working, and gives you and your doctor something concrete to adjust. Clarity’s pattern alerts are designed to surface these actionable moments, though how much a user benefits depends heavily on whether they actually review the reports and adjust behavior accordingly.

What Happens When People Actually Review Their Reports

Having access to data and acting on it are two different things. Researchers have explored whether retrospective review of CGM summary reports, the kind of review Clarity makes possible, actually changes how people feel about their diabetes and how well they manage it. The results are encouraging. In a study examining the personal use of real-time CGM data, about three-quarters of participants said that receiving and viewing a weekly summary report contributed to improved confidence around hypoglycemia, and a similar proportion said it helped improve their HbA1c. Roughly 60–74% reported reduced diabetes distress, and about 62% said it helped reduce problems with low blood sugar.⁸

An interesting finding from that same research was that people who regularly reviewed their reports with family members or friends reported better outcomes than those who reviewed alone, while people who received the report but did nothing with the information saw little benefit. The data sitting passively in Clarity doesn’t help. Opening the app, looking at the trends, and ideally talking through what you see with someone else is what seems to drive the improvement. The platform provides the opportunity; the user has to meet it halfway.

This aligns with broader evidence that both retrospective trend data and real-time alarms from CGM systems can motivate and support behavior change in diabetes management.⁹ Clarity occupies the retrospective side of that equation, giving you the bigger picture that moment-to-moment glucose readings can’t provide.

Sharing Data With Providers and Family

One of Clarity’s most practical features is its sharing functionality. You can grant your endocrinologist, diabetes educator, or primary care provider access to your Clarity account so they can pull up your AGP report and detailed glucose data before or during appointments. Clinicians increasingly use the AGP as a systematic framework to understand a patient’s current glycemic control and to monitor the real-time impact of therapy adjustments for both type 1 and type 2 diabetes.² The standardized format of the report means a provider who has never seen you before can quickly interpret your glucose patterns without needing to learn a proprietary interface.

For families managing a child’s type 1 diabetes, the ability to share data remotely can be transformative. A pilot trial examining caregiver experiences with a digital health platform that integrated CGM data found that caregivers described the platform as convenient because it connected them to their child’s device data and the healthcare team in one place. Caregivers also reported feeling empowered to review glucose trends and adjust insulin doses between appointments, rather than waiting for an in-person visit to make changes. Nearly all felt more prepared when they did go to clinic, partly because the data was already organized and accessible.¹⁰ While that study examined a broader digital health platform rather than Clarity specifically, the core dynamic, connecting caregivers to their child’s CGM data and the care team, mirrors exactly what Clarity’s sharing features are designed to support.

Clarity for Type 2 Diabetes Without Insulin

Clarity was originally built around Dexcom’s CGM hardware, which for years was used almost exclusively by people with type 1 diabetes or insulin-dependent type 2. That has been changing. A large real-world study of adults with suboptimally controlled type 2 diabetes who were not using insulin found that Dexcom CGM use was associated with meaningful improvements in glycemic control over 12 months. Notably, people who used the CGM’s high glucose alert system saw better outcomes, and high sensor-wear consistency over the full year suggested that the benefits are tied to sustained engagement rather than a brief learning phase.¹¹

For someone managing type 2 diabetes with diet, exercise, and oral medications, Clarity offers a different kind of value than it does for a person on an insulin pump. There are no basal rates to tweak. Instead, the reports can reveal which meals reliably cause spikes, whether a new exercise routine is making a measurable difference, or whether a medication change is working before the next lab appointment rolls around. The feedback loop is faster and more concrete than checking a fasting glucose each morning.

The Interpretation Gap

For all its polish, Clarity and similar CGM data platforms face a real challenge: many users struggle to correctly interpret what the charts are actually telling them. A study examining how people with type 1 diabetes interpreted glucose data interfaces found that interpretation accuracy was surprisingly low across all device types, averaging around 38% for CGM users. Treatment action accuracy, meaning the ability to select the right next step based on what the data showed, was even lower at roughly 22%.¹²

Those numbers are sobering. They suggest that having beautiful, standardized reports is necessary but not sufficient. A sizable proportion of users look at an AGP, misread the pattern, and choose an action that doesn’t match what the data is telling them. Part of this is an education problem that clinicians and diabetes educators are actively working to address. Part of it is a design problem. The clinical expert panel that originally recommended the AGP acknowledged the need for new tools to help both clinicians and patients interpret AGP data effectively.¹³ If you are new to Clarity, asking your diabetes care team to walk you through your first few reports is time well spent.

Privacy Concerns With CGM Data

Clarity stores granular health data in the cloud, and that raises legitimate privacy questions. Your glucose readings, patterns of highs and lows, estimated HbA1c, and potentially identifying health information all live on Dexcom’s servers. A review of privacy and security issues around CGM data concluded that existing protections were not robust enough to address the risks associated with continuous glucose monitoring platforms and the apps that communicate with them.¹⁴

In the United States, health data stored by Dexcom falls under HIPAA protections when it flows through a healthcare provider relationship, but data generated and stored directly by a consumer device and app can occupy a murkier legal space. Dexcom’s privacy policy governs how your data can be shared, used for research, or anonymized and aggregated. If you share your Clarity data with a clinic, that creates an additional data pathway with its own security considerations. None of this is unique to Dexcom. Every digital health platform handling continuous biometric data faces similar questions, and the regulatory landscape is still catching up to the technology.

Who Can Access Clarity and Cost Barriers

Clarity itself is free to download and use. The cost barrier lies with the Dexcom CGM hardware that feeds it. A Dexcom G7 sensor and transmitter require either insurance coverage or out-of-pocket spending that can run into hundreds of dollars a month. Insurance coverage for CGM varies widely by plan and by country, and research on digital health app engagement has found that socioeconomic differences influence who sustains use of these tools. One study found that sustained users of a diabetes management app were more likely to have private insurance and less likely to have Medicaid.¹⁵ While that study examined a different app, the pattern applies broadly to digital diabetes tools: the people who benefit most from these platforms tend to already have greater resources.

Clarity also requires a smartphone or computer and a reliable internet connection to sync and display data. For people managing diabetes in under-resourced settings, the software itself being free doesn’t resolve the access equation. This is an ongoing tension across digital health, not a flaw specific to Clarity.

Where Machine Learning Fits In

The next frontier for platforms like Clarity involves using machine learning to move from retrospective pattern recognition to predictive glucose forecasting. Research exploring this space has investigated algorithms that can predict blood glucose levels using CGM data with relatively few additional inputs. One study using data from over 14,000 patients tested multiple machine learning approaches and achieved prediction accuracies above 92% with the best-performing models.¹⁶

Dexcom has not publicly detailed whether Clarity currently uses machine learning models of this sophistication internally, but the direction of travel across the CGM industry is clearly toward software that doesn’t just report what happened but warns you about what is likely to happen next. For Clarity users, this could eventually mean opening the app and seeing not just yesterday’s patterns but a forecast of today’s likely glucose trajectory based on your personal history, recent meals, and activity. That shift, from a rearview mirror to a windshield, is where the real value of continuous data platforms is heading.